AU2002368245A1 - Matrix type patch for transdermal administration of vitamin d analog and the use thereof - Google Patents

Matrix type patch for transdermal administration of vitamin d analog and the use thereof

Info

Publication number
AU2002368245A1
AU2002368245A1 AU2002368245A AU2002368245A AU2002368245A1 AU 2002368245 A1 AU2002368245 A1 AU 2002368245A1 AU 2002368245 A AU2002368245 A AU 2002368245A AU 2002368245 A AU2002368245 A AU 2002368245A AU 2002368245 A1 AU2002368245 A1 AU 2002368245A1
Authority
AU
Australia
Prior art keywords
vitamin
analog
matrix type
transdermal administration
type patch
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002368245A
Inventor
Young-Kweon Choi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU2002368245A1 publication Critical patent/AU2002368245A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7069—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained otherwise than by reactions only involving carbon to carbon unsaturated bonds, e.g. polysiloxane, polyesters, polyurethane, polyethylene oxide
AU2002368245A 2002-09-26 2002-09-26 Matrix type patch for transdermal administration of vitamin d analog and the use thereof Abandoned AU2002368245A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/KR2002/001809 WO2004028515A1 (en) 2002-09-26 2002-09-26 Matrix type patch for transdermal administration of vitamin d analog and the use thereof

Publications (1)

Publication Number Publication Date
AU2002368245A1 true AU2002368245A1 (en) 2004-04-19

Family

ID=32040900

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002368245A Abandoned AU2002368245A1 (en) 2002-09-26 2002-09-26 Matrix type patch for transdermal administration of vitamin d analog and the use thereof

Country Status (2)

Country Link
AU (1) AU2002368245A1 (en)
WO (1) WO2004028515A1 (en)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050148557A1 (en) * 2003-07-29 2005-07-07 Jin Tian Use of Vitamin Ds to treat kidney disease
US20050192255A1 (en) * 2003-07-30 2005-09-01 Jin Tian Use of Vitamin Ds or Vitamin D analogs to treat cardiovascular disease
FR2887150B1 (en) * 2005-06-17 2007-08-03 Galderma Res & Dev PHARMACEUTICAL COMPOSITION COMPRISING AN ORGANOPOLYSILOXANE ELASTOMER AND A SOLUBILIZED ACTIVE INGREDIENT
WO2006133828A1 (en) * 2005-06-17 2006-12-21 Dsm Ip Assets B.V. Novel use 25-hydroxycholecalciferol in combination with uv-b screening agents
PL1993559T3 (en) 2006-02-03 2017-01-31 Opko Renal, Llc Treating vitamin d insufficiency and deficiency with 25-hydroxyvitamin d2 and 25-hydroxyvitamin d3
LT2679228T (en) 2006-06-21 2018-05-10 Opko Ireland Global Holdings, Ltd. Therapy using vitamin D repletion agent and vitamin D hormone replacement agent
JP5647516B2 (en) 2007-04-25 2014-12-24 シトクロマ インコーポレイテッド Methods and compounds for vitamin D therapy
WO2008134512A1 (en) 2007-04-25 2008-11-06 Cytochroma Inc. Oral controlled release compositions comprising vitamin d compound and waxy carrier
KR101495578B1 (en) * 2007-04-25 2015-02-25 사이토크로마 인코포레이티드 Method of treating vitamin d insufficiency and deficiency
JP2010525080A (en) 2007-04-25 2010-07-22 プロヴェンティヴ セラピュティックス リミテッド ライアビリティ カンパニー Safe and effective treatment and prevention method for secondary hyperparathyroidism in chronic kidney disease
ES2954932T3 (en) 2008-04-02 2023-11-27 Eirgen Pharma Ltd Useful methods, compositions, uses and kits for vitamin D deficiency and related disorders
KR102125424B1 (en) 2010-03-29 2020-06-22 사이토크로마 인코포레이티드 Methods and compositions for reducing parathyroid levels
KR101847947B1 (en) 2013-03-15 2018-05-28 옵코 아이피 홀딩스 Ⅱ 인코포레이티드 Stabilized modified release vitamin d formulation
CR20170085A (en) 2014-08-07 2017-04-25 Opko Ireland Global Holdings Ltd ADJUNCTIVE THERAPY WITH 25-HYDROXY VITAMIN D
WO2016205245A1 (en) * 2015-06-14 2016-12-22 Technology Recovery Systems Llc Transdermal delivery formulation
JP7032322B2 (en) 2016-03-28 2022-03-08 オプコ アイルランド グローバル ホールディングス リミテッド Vitamin D treatment
CN110731952A (en) * 2018-07-18 2020-01-31 郑州泰丰制药有限公司 calcitriol patch and its preparation method
CL2018003823A1 (en) * 2018-12-27 2019-03-29 Univ De Santiago De Chile 50% Material that incorporates vitamin D for later release and method to obtain said material

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4849224A (en) * 1987-11-12 1989-07-18 Theratech Inc. Device for administering an active agent to the skin or mucosa
US5602116A (en) * 1988-08-02 1997-02-11 Bone Care International, Inc. Method for treating and preventing secondary hyperparathyroidism
DE4328217C2 (en) * 1993-08-21 1996-01-11 Lohmann Therapie Syst Lts Therapeutic system for the treatment of psoriasis
IL110117A0 (en) * 1994-06-24 1994-10-07 Univ Ben Gurion Pharmaceutical compositions comprising vitamin-d analogs
KR100438254B1 (en) * 2001-03-29 2004-07-02 아이큐어 주식회사 Matrix form of preparation for transdermal administration of vitamin d analog

Also Published As

Publication number Publication date
WO2004028515A1 (en) 2004-04-08

Similar Documents

Publication Publication Date Title
AU2002368245A1 (en) Matrix type patch for transdermal administration of vitamin d analog and the use thereof
AU2003221770A1 (en) Controlled release transdermal drug delivery
AU2003228442A1 (en) Ophthalmic, pharmaceutical and other healthcare preparations with naturally occuring plant compounds, extracts and derivatives
AU2003234231A1 (en) New polyarylates for drug delivery and tissue engineering
AU2003289641A1 (en) The novel coumarin-amide derivatives and its preparation, said drug composition and its use
AU2003261935A1 (en) Furan or thiophene derivative and medicinal use thereof
AU2003252478A1 (en) Ccr4 antagonist and medicinal use thereof
IL157822A (en) Transdermal patch for administering fentanyl or an analog thereof
AU2002246152A1 (en) Utilization of pyrazoline derivatives in the preparation of a medicament for the prevention and/or treatment of proliferative cell diseases
AU2003222347A1 (en) Novel peptide derivatives, preparation and therapeutic and cosmetic application thereof
AU2002354054A1 (en) Spiroheterocyclic derivative compounds and drugs comprising the compounds as the active ingredient
AU2003255645A1 (en) Piperazinylacylpiperidine derivatives, their preparation and therapeutic use thereof
AU2003221173A1 (en) Placenta-origin mesenchymal cells and medicinal use thereof
AU2003235956A1 (en) Quinazoline derivative and medicine
AU2003269018A1 (en) Acylaminothiazole derivatives, preparation and therapeutic use thereof
AU2003246567A1 (en) Administration form for the oral administration of active substances, vitamins, and/or nutrients
AU2003281687A1 (en) Photopolymerizable composition and use thereof
AU2003281358A1 (en) Pin1 peptidyl-prolyl isomerase polypeptides, their crystal structures, and use thereof for drug design
AU2003262230A1 (en) Preventive and/or therapeutic drugs for itch
AU2003246566A1 (en) Administration form for the oral administration of active substances, vitamins, and/or nutrients
AU2003264406A1 (en) Drug or cosmetic
AU2003251513A1 (en) Rsk inhibitors and therapeutic uses thereof
AU2003269810A1 (en) Pyrroloquinoline quinone drugs as a neuroprotectant and methods of use thereof
AU2003206872A1 (en) Derivatives of (1-benzyl-piperidine-4-yl)-diphenyl-methanol and their use as pesticide
AU2003252337A1 (en) Patch for transdermal administration

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase